nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—Ibuprofen—UGT2B7—urinary bladder cancer	0.011	0.472	CrCbGaD
Sotalol—Ibuprofen—CXCL8—urinary bladder cancer	0.00619	0.266	CrCbGaD
Sotalol—Ibuprofen—PPARG—urinary bladder cancer	0.00428	0.184	CrCbGaD
Sotalol—Ibuprofen—PTGS2—urinary bladder cancer	0.00181	0.0777	CrCbGaD
Sotalol—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00149	0.00152	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00149	0.00152	CcSEcCtD
Sotalol—Insomnia—Gemcitabine—urinary bladder cancer	0.00148	0.00151	CcSEcCtD
Sotalol—Hypertension—Etoposide—urinary bladder cancer	0.00147	0.00151	CcSEcCtD
Sotalol—Pain in extremity—Doxorubicin—urinary bladder cancer	0.00147	0.00151	CcSEcCtD
Sotalol—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00147	0.00151	CcSEcCtD
Sotalol—Asthma—Methotrexate—urinary bladder cancer	0.00147	0.0015	CcSEcCtD
Sotalol—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00147	0.0015	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00146	0.0015	CcSEcCtD
Sotalol—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00145	0.00149	CcSEcCtD
Sotalol—Chest pain—Etoposide—urinary bladder cancer	0.00145	0.00149	CcSEcCtD
Sotalol—Eosinophilia—Methotrexate—urinary bladder cancer	0.00145	0.00149	CcSEcCtD
Sotalol—Insomnia—Fluorouracil—urinary bladder cancer	0.00145	0.00149	CcSEcCtD
Sotalol—Somnolence—Gemcitabine—urinary bladder cancer	0.00145	0.00149	CcSEcCtD
Sotalol—Affect lability—Doxorubicin—urinary bladder cancer	0.00145	0.00148	CcSEcCtD
Sotalol—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00144	0.00148	CcSEcCtD
Sotalol—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00143	0.00146	CcSEcCtD
Sotalol—Somnolence—Fluorouracil—urinary bladder cancer	0.00143	0.00146	CcSEcCtD
Sotalol—Hypotension—Cisplatin—urinary bladder cancer	0.00142	0.00146	CcSEcCtD
Sotalol—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00142	0.00145	CcSEcCtD
Sotalol—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00141	0.00145	CcSEcCtD
Sotalol—Fatigue—Gemcitabine—urinary bladder cancer	0.00141	0.00144	CcSEcCtD
Sotalol—Pain—Gemcitabine—urinary bladder cancer	0.0014	0.00143	CcSEcCtD
Sotalol—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00139	0.00143	CcSEcCtD
Sotalol—Mood swings—Doxorubicin—urinary bladder cancer	0.00139	0.00143	CcSEcCtD
Sotalol—Asthenia—Thiotepa—urinary bladder cancer	0.00139	0.00143	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00139	0.00142	CcSEcCtD
Sotalol—Infection—Etoposide—urinary bladder cancer	0.00138	0.00142	CcSEcCtD
Sotalol—Abdominal distension—Epirubicin—urinary bladder cancer	0.00138	0.00142	CcSEcCtD
Sotalol—Influenza—Epirubicin—urinary bladder cancer	0.00137	0.00141	CcSEcCtD
Sotalol—Asthma—Epirubicin—urinary bladder cancer	0.00137	0.00141	CcSEcCtD
Sotalol—Pruritus—Thiotepa—urinary bladder cancer	0.00137	0.00141	CcSEcCtD
Sotalol—Pain—Fluorouracil—urinary bladder cancer	0.00137	0.0014	CcSEcCtD
Sotalol—Paraesthesia—Cisplatin—urinary bladder cancer	0.00137	0.0014	CcSEcCtD
Sotalol—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00136	0.0014	CcSEcCtD
Sotalol—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.00136	0.0014	CcSEcCtD
Sotalol—Eosinophilia—Epirubicin—urinary bladder cancer	0.00136	0.00139	CcSEcCtD
Sotalol—Dyspnoea—Cisplatin—urinary bladder cancer	0.00136	0.00139	CcSEcCtD
Sotalol—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00135	0.00138	CcSEcCtD
Sotalol—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00134	0.00137	CcSEcCtD
Sotalol—Angina pectoris—Epirubicin—urinary bladder cancer	0.00134	0.00137	CcSEcCtD
Sotalol—Diarrhoea—Thiotepa—urinary bladder cancer	0.00133	0.00136	CcSEcCtD
Sotalol—Decreased appetite—Cisplatin—urinary bladder cancer	0.00132	0.00135	CcSEcCtD
Sotalol—Drowsiness—Methotrexate—urinary bladder cancer	0.00131	0.00134	CcSEcCtD
Sotalol—Depression—Methotrexate—urinary bladder cancer	0.00131	0.00134	CcSEcCtD
Sotalol—Hypotension—Etoposide—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Sotalol—Pain—Cisplatin—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Sotalol—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00129	0.00132	CcSEcCtD
Sotalol—Dizziness—Thiotepa—urinary bladder cancer	0.00128	0.00131	CcSEcCtD
Sotalol—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00128	0.00131	CcSEcCtD
Sotalol—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.00128	0.00131	CcSEcCtD
Sotalol—Asthma—Doxorubicin—urinary bladder cancer	0.00127	0.0013	CcSEcCtD
Sotalol—Influenza—Doxorubicin—urinary bladder cancer	0.00127	0.0013	CcSEcCtD
Sotalol—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00127	0.0013	CcSEcCtD
Sotalol—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00126	0.00129	CcSEcCtD
Sotalol—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00125	0.00128	CcSEcCtD
Sotalol—Paraesthesia—Etoposide—urinary bladder cancer	0.00125	0.00128	CcSEcCtD
Sotalol—Dyspnoea—Etoposide—urinary bladder cancer	0.00124	0.00127	CcSEcCtD
Sotalol—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.00124	0.00127	CcSEcCtD
Sotalol—Somnolence—Etoposide—urinary bladder cancer	0.00124	0.00127	CcSEcCtD
Sotalol—Angina pectoris—Doxorubicin—urinary bladder cancer	0.00124	0.00127	CcSEcCtD
Sotalol—Vomiting—Thiotepa—urinary bladder cancer	0.00123	0.00126	CcSEcCtD
Sotalol—Drowsiness—Epirubicin—urinary bladder cancer	0.00122	0.00125	CcSEcCtD
Sotalol—Rash—Thiotepa—urinary bladder cancer	0.00122	0.00125	CcSEcCtD
Sotalol—Dermatitis—Thiotepa—urinary bladder cancer	0.00122	0.00125	CcSEcCtD
Sotalol—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00122	0.00125	CcSEcCtD
Sotalol—Headache—Thiotepa—urinary bladder cancer	0.00122	0.00124	CcSEcCtD
Sotalol—Decreased appetite—Etoposide—urinary bladder cancer	0.00121	0.00124	CcSEcCtD
Sotalol—Body temperature increased—Cisplatin—urinary bladder cancer	0.0012	0.00123	CcSEcCtD
Sotalol—Fatigue—Etoposide—urinary bladder cancer	0.0012	0.00123	CcSEcCtD
Sotalol—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.0012	0.00123	CcSEcCtD
Sotalol—Pain—Etoposide—urinary bladder cancer	0.00119	0.00122	CcSEcCtD
Sotalol—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00118	0.00121	CcSEcCtD
Sotalol—Haemoglobin—Methotrexate—urinary bladder cancer	0.00118	0.00121	CcSEcCtD
Sotalol—Haemorrhage—Methotrexate—urinary bladder cancer	0.00117	0.0012	CcSEcCtD
Sotalol—Asthenia—Gemcitabine—urinary bladder cancer	0.00117	0.0012	CcSEcCtD
Sotalol—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00116	0.00119	CcSEcCtD
Sotalol—Pruritus—Gemcitabine—urinary bladder cancer	0.00115	0.00118	CcSEcCtD
Sotalol—Nausea—Thiotepa—urinary bladder cancer	0.00115	0.00118	CcSEcCtD
Sotalol—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.00115	0.00117	CcSEcCtD
Sotalol—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00114	0.00117	CcSEcCtD
Sotalol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00114	0.00117	CcSEcCtD
Sotalol—Pruritus—Fluorouracil—urinary bladder cancer	0.00114	0.00116	CcSEcCtD
Sotalol—Drowsiness—Doxorubicin—urinary bladder cancer	0.00113	0.00116	CcSEcCtD
Sotalol—Visual impairment—Methotrexate—urinary bladder cancer	0.00113	0.00116	CcSEcCtD
Sotalol—Bradycardia—Epirubicin—urinary bladder cancer	0.00112	0.00115	CcSEcCtD
Sotalol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Sotalol—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00111	0.00114	CcSEcCtD
Sotalol—Haemoglobin—Epirubicin—urinary bladder cancer	0.00111	0.00113	CcSEcCtD
Sotalol—Abdominal pain—Etoposide—urinary bladder cancer	0.0011	0.00113	CcSEcCtD
Sotalol—Body temperature increased—Etoposide—urinary bladder cancer	0.0011	0.00113	CcSEcCtD
Sotalol—Haemorrhage—Epirubicin—urinary bladder cancer	0.0011	0.00113	CcSEcCtD
Sotalol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.0011	0.00112	CcSEcCtD
Sotalol—Asthenia—Cisplatin—urinary bladder cancer	0.00109	0.00112	CcSEcCtD
Sotalol—Angiopathy—Methotrexate—urinary bladder cancer	0.00107	0.00109	CcSEcCtD
Sotalol—Dizziness—Fluorouracil—urinary bladder cancer	0.00106	0.00109	CcSEcCtD
Sotalol—Visual impairment—Epirubicin—urinary bladder cancer	0.00106	0.00108	CcSEcCtD
Sotalol—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00106	0.00108	CcSEcCtD
Sotalol—Diarrhoea—Cisplatin—urinary bladder cancer	0.00104	0.00107	CcSEcCtD
Sotalol—Alopecia—Methotrexate—urinary bladder cancer	0.00104	0.00106	CcSEcCtD
Sotalol—Vomiting—Gemcitabine—urinary bladder cancer	0.00104	0.00106	CcSEcCtD
Sotalol—Bradycardia—Doxorubicin—urinary bladder cancer	0.00104	0.00106	CcSEcCtD
Sotalol—Rash—Gemcitabine—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Sotalol—Dermatitis—Gemcitabine—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Sotalol—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00102	0.00105	CcSEcCtD
Sotalol—Headache—Gemcitabine—urinary bladder cancer	0.00102	0.00105	CcSEcCtD
Sotalol—Vomiting—Fluorouracil—urinary bladder cancer	0.00102	0.00104	CcSEcCtD
Sotalol—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00102	0.00104	CcSEcCtD
Sotalol—Rash—Fluorouracil—urinary bladder cancer	0.00101	0.00104	CcSEcCtD
Sotalol—Dermatitis—Fluorouracil—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Sotalol—Headache—Fluorouracil—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Sotalol—Dysgeusia—Methotrexate—urinary bladder cancer	0.001	0.00103	CcSEcCtD
Sotalol—Asthenia—Etoposide—urinary bladder cancer	0.001	0.00102	CcSEcCtD
Sotalol—Angiopathy—Epirubicin—urinary bladder cancer	0.000998	0.00102	CcSEcCtD
Sotalol—Back pain—Methotrexate—urinary bladder cancer	0.000989	0.00101	CcSEcCtD
Sotalol—Pruritus—Etoposide—urinary bladder cancer	0.000986	0.00101	CcSEcCtD
Sotalol—Arrhythmia—Epirubicin—urinary bladder cancer	0.000982	0.00101	CcSEcCtD
Sotalol—Visual impairment—Doxorubicin—urinary bladder cancer	0.00098	0.001	CcSEcCtD
Sotalol—Alopecia—Epirubicin—urinary bladder cancer	0.000972	0.000995	CcSEcCtD
Sotalol—Nausea—Gemcitabine—urinary bladder cancer	0.000969	0.000992	CcSEcCtD
Sotalol—Vomiting—Cisplatin—urinary bladder cancer	0.000967	0.00099	CcSEcCtD
Sotalol—Vision blurred—Methotrexate—urinary bladder cancer	0.000964	0.000987	CcSEcCtD
Sotalol—Rash—Cisplatin—urinary bladder cancer	0.000959	0.000982	CcSEcCtD
Sotalol—Dermatitis—Cisplatin—urinary bladder cancer	0.000958	0.000981	CcSEcCtD
Sotalol—Diarrhoea—Etoposide—urinary bladder cancer	0.000953	0.000976	CcSEcCtD
Sotalol—Nausea—Fluorouracil—urinary bladder cancer	0.000953	0.000976	CcSEcCtD
Sotalol—Flatulence—Epirubicin—urinary bladder cancer	0.000943	0.000966	CcSEcCtD
Sotalol—Dysgeusia—Epirubicin—urinary bladder cancer	0.000937	0.00096	CcSEcCtD
Sotalol—Back pain—Epirubicin—urinary bladder cancer	0.000926	0.000948	CcSEcCtD
Sotalol—Angiopathy—Doxorubicin—urinary bladder cancer	0.000923	0.000945	CcSEcCtD
Sotalol—Dizziness—Etoposide—urinary bladder cancer	0.000922	0.000943	CcSEcCtD
Sotalol—Muscle spasms—Epirubicin—urinary bladder cancer	0.00092	0.000942	CcSEcCtD
Sotalol—Vertigo—Methotrexate—urinary bladder cancer	0.000919	0.000941	CcSEcCtD
Sotalol—Leukopenia—Methotrexate—urinary bladder cancer	0.000916	0.000937	CcSEcCtD
Sotalol—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000909	0.00093	CcSEcCtD
Sotalol—Nausea—Cisplatin—urinary bladder cancer	0.000904	0.000925	CcSEcCtD
Sotalol—Vision blurred—Epirubicin—urinary bladder cancer	0.000902	0.000923	CcSEcCtD
Sotalol—Alopecia—Doxorubicin—urinary bladder cancer	0.000899	0.00092	CcSEcCtD
Sotalol—Cough—Methotrexate—urinary bladder cancer	0.000892	0.000914	CcSEcCtD
Sotalol—Vomiting—Etoposide—urinary bladder cancer	0.000886	0.000907	CcSEcCtD
Sotalol—Rash—Etoposide—urinary bladder cancer	0.000879	0.0009	CcSEcCtD
Sotalol—Dermatitis—Etoposide—urinary bladder cancer	0.000878	0.000899	CcSEcCtD
Sotalol—Headache—Etoposide—urinary bladder cancer	0.000873	0.000894	CcSEcCtD
Sotalol—Flatulence—Doxorubicin—urinary bladder cancer	0.000873	0.000893	CcSEcCtD
Sotalol—Myalgia—Methotrexate—urinary bladder cancer	0.000871	0.000891	CcSEcCtD
Sotalol—Chest pain—Methotrexate—urinary bladder cancer	0.000871	0.000891	CcSEcCtD
Sotalol—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000867	0.000888	CcSEcCtD
Sotalol—Vertigo—Epirubicin—urinary bladder cancer	0.00086	0.00088	CcSEcCtD
Sotalol—Syncope—Epirubicin—urinary bladder cancer	0.000858	0.000879	CcSEcCtD
Sotalol—Leukopenia—Epirubicin—urinary bladder cancer	0.000857	0.000877	CcSEcCtD
Sotalol—Back pain—Doxorubicin—urinary bladder cancer	0.000857	0.000877	CcSEcCtD
Sotalol—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000851	0.000872	CcSEcCtD
Sotalol—Palpitations—Epirubicin—urinary bladder cancer	0.000846	0.000866	CcSEcCtD
Sotalol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000841	0.000861	CcSEcCtD
Sotalol—Cough—Epirubicin—urinary bladder cancer	0.000835	0.000855	CcSEcCtD
Sotalol—Vision blurred—Doxorubicin—urinary bladder cancer	0.000835	0.000854	CcSEcCtD
Sotalol—Infection—Methotrexate—urinary bladder cancer	0.000829	0.000849	CcSEcCtD
Sotalol—Nausea—Etoposide—urinary bladder cancer	0.000828	0.000847	CcSEcCtD
Sotalol—Hypertension—Epirubicin—urinary bladder cancer	0.000826	0.000846	CcSEcCtD
Sotalol—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000817	0.000837	CcSEcCtD
Sotalol—Myalgia—Epirubicin—urinary bladder cancer	0.000815	0.000834	CcSEcCtD
Sotalol—Chest pain—Epirubicin—urinary bladder cancer	0.000815	0.000834	CcSEcCtD
Sotalol—Anxiety—Epirubicin—urinary bladder cancer	0.000812	0.000831	CcSEcCtD
Sotalol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000807	0.000826	CcSEcCtD
Sotalol—Vertigo—Doxorubicin—urinary bladder cancer	0.000796	0.000815	CcSEcCtD
Sotalol—Syncope—Doxorubicin—urinary bladder cancer	0.000794	0.000813	CcSEcCtD
Sotalol—Leukopenia—Doxorubicin—urinary bladder cancer	0.000793	0.000812	CcSEcCtD
Sotalol—Palpitations—Doxorubicin—urinary bladder cancer	0.000783	0.000801	CcSEcCtD
Sotalol—Oedema—Epirubicin—urinary bladder cancer	0.000781	0.0008	CcSEcCtD
Sotalol—Hypotension—Methotrexate—urinary bladder cancer	0.00078	0.000799	CcSEcCtD
Sotalol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000778	0.000797	CcSEcCtD
Sotalol—Infection—Epirubicin—urinary bladder cancer	0.000776	0.000795	CcSEcCtD
Sotalol—Cough—Doxorubicin—urinary bladder cancer	0.000773	0.000791	CcSEcCtD
Sotalol—Shock—Epirubicin—urinary bladder cancer	0.000769	0.000787	CcSEcCtD
Sotalol—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000765	0.000783	CcSEcCtD
Sotalol—Hypertension—Doxorubicin—urinary bladder cancer	0.000765	0.000783	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00076	0.000779	CcSEcCtD
Sotalol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000755	0.000773	CcSEcCtD
Sotalol—Insomnia—Methotrexate—urinary bladder cancer	0.000755	0.000773	CcSEcCtD
Sotalol—Chest pain—Doxorubicin—urinary bladder cancer	0.000754	0.000772	CcSEcCtD
Sotalol—Myalgia—Doxorubicin—urinary bladder cancer	0.000754	0.000772	CcSEcCtD
Sotalol—Anxiety—Doxorubicin—urinary bladder cancer	0.000751	0.000769	CcSEcCtD
Sotalol—Paraesthesia—Methotrexate—urinary bladder cancer	0.00075	0.000767	CcSEcCtD
Sotalol—Dyspnoea—Methotrexate—urinary bladder cancer	0.000744	0.000762	CcSEcCtD
Sotalol—Somnolence—Methotrexate—urinary bladder cancer	0.000742	0.00076	CcSEcCtD
Sotalol—Dyspepsia—Methotrexate—urinary bladder cancer	0.000735	0.000752	CcSEcCtD
Sotalol—Hypotension—Epirubicin—urinary bladder cancer	0.00073	0.000747	CcSEcCtD
Sotalol—Decreased appetite—Methotrexate—urinary bladder cancer	0.000726	0.000743	CcSEcCtD
Sotalol—Oedema—Doxorubicin—urinary bladder cancer	0.000723	0.00074	CcSEcCtD
Sotalol—Fatigue—Methotrexate—urinary bladder cancer	0.00072	0.000737	CcSEcCtD
Sotalol—Infection—Doxorubicin—urinary bladder cancer	0.000718	0.000735	CcSEcCtD
Sotalol—Pain—Methotrexate—urinary bladder cancer	0.000714	0.000731	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000712	0.000729	CcSEcCtD
Sotalol—Shock—Doxorubicin—urinary bladder cancer	0.000711	0.000728	CcSEcCtD
Sotalol—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000708	0.000725	CcSEcCtD
Sotalol—Insomnia—Epirubicin—urinary bladder cancer	0.000707	0.000723	CcSEcCtD
Sotalol—Paraesthesia—Epirubicin—urinary bladder cancer	0.000701	0.000718	CcSEcCtD
Sotalol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000699	0.000715	CcSEcCtD
Sotalol—Dyspnoea—Epirubicin—urinary bladder cancer	0.000696	0.000713	CcSEcCtD
Sotalol—Somnolence—Epirubicin—urinary bladder cancer	0.000694	0.000711	CcSEcCtD
Sotalol—Dyspepsia—Epirubicin—urinary bladder cancer	0.000688	0.000704	CcSEcCtD
Sotalol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000683	0.000699	CcSEcCtD
Sotalol—Decreased appetite—Epirubicin—urinary bladder cancer	0.000679	0.000695	CcSEcCtD
Sotalol—Hypotension—Doxorubicin—urinary bladder cancer	0.000675	0.000691	CcSEcCtD
Sotalol—Fatigue—Epirubicin—urinary bladder cancer	0.000673	0.000689	CcSEcCtD
Sotalol—Pain—Epirubicin—urinary bladder cancer	0.000668	0.000684	CcSEcCtD
Sotalol—Abdominal pain—Methotrexate—urinary bladder cancer	0.00066	0.000676	CcSEcCtD
Sotalol—Body temperature increased—Methotrexate—urinary bladder cancer	0.00066	0.000676	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000659	0.000674	CcSEcCtD
Sotalol—Insomnia—Doxorubicin—urinary bladder cancer	0.000654	0.000669	CcSEcCtD
Sotalol—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000649	0.000664	CcSEcCtD
Sotalol—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000644	0.00066	CcSEcCtD
Sotalol—Somnolence—Doxorubicin—urinary bladder cancer	0.000643	0.000658	CcSEcCtD
Sotalol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000639	0.000654	CcSEcCtD
Sotalol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000636	0.000651	CcSEcCtD
Sotalol—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000628	0.000643	CcSEcCtD
Sotalol—Fatigue—Doxorubicin—urinary bladder cancer	0.000623	0.000638	CcSEcCtD
Sotalol—Pain—Doxorubicin—urinary bladder cancer	0.000618	0.000633	CcSEcCtD
Sotalol—Abdominal pain—Epirubicin—urinary bladder cancer	0.000618	0.000632	CcSEcCtD
Sotalol—Body temperature increased—Epirubicin—urinary bladder cancer	0.000618	0.000632	CcSEcCtD
Sotalol—Asthenia—Methotrexate—urinary bladder cancer	0.000599	0.000613	CcSEcCtD
Sotalol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000591	0.000605	CcSEcCtD
Sotalol—Pruritus—Methotrexate—urinary bladder cancer	0.000591	0.000605	CcSEcCtD
Sotalol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000571	0.000585	CcSEcCtD
Sotalol—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000571	0.000585	CcSEcCtD
Sotalol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000571	0.000585	CcSEcCtD
Sotalol—Asthenia—Epirubicin—urinary bladder cancer	0.00056	0.000574	CcSEcCtD
Sotalol—Pruritus—Epirubicin—urinary bladder cancer	0.000553	0.000566	CcSEcCtD
Sotalol—Dizziness—Methotrexate—urinary bladder cancer	0.000552	0.000565	CcSEcCtD
Sotalol—Diarrhoea—Epirubicin—urinary bladder cancer	0.000534	0.000547	CcSEcCtD
Sotalol—Vomiting—Methotrexate—urinary bladder cancer	0.000531	0.000543	CcSEcCtD
Sotalol—Rash—Methotrexate—urinary bladder cancer	0.000526	0.000539	CcSEcCtD
Sotalol—Dermatitis—Methotrexate—urinary bladder cancer	0.000526	0.000538	CcSEcCtD
Sotalol—Headache—Methotrexate—urinary bladder cancer	0.000523	0.000535	CcSEcCtD
Sotalol—Asthenia—Doxorubicin—urinary bladder cancer	0.000519	0.000531	CcSEcCtD
Sotalol—Dizziness—Epirubicin—urinary bladder cancer	0.000517	0.000529	CcSEcCtD
Sotalol—Pruritus—Doxorubicin—urinary bladder cancer	0.000511	0.000524	CcSEcCtD
Sotalol—Vomiting—Epirubicin—urinary bladder cancer	0.000497	0.000508	CcSEcCtD
Sotalol—Nausea—Methotrexate—urinary bladder cancer	0.000496	0.000508	CcSEcCtD
Sotalol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000495	0.000506	CcSEcCtD
Sotalol—Rash—Epirubicin—urinary bladder cancer	0.000493	0.000504	CcSEcCtD
Sotalol—Dermatitis—Epirubicin—urinary bladder cancer	0.000492	0.000504	CcSEcCtD
Sotalol—Headache—Epirubicin—urinary bladder cancer	0.000489	0.000501	CcSEcCtD
Sotalol—Dizziness—Doxorubicin—urinary bladder cancer	0.000478	0.000489	CcSEcCtD
Sotalol—Nausea—Epirubicin—urinary bladder cancer	0.000464	0.000475	CcSEcCtD
Sotalol—Vomiting—Doxorubicin—urinary bladder cancer	0.00046	0.00047	CcSEcCtD
Sotalol—Rash—Doxorubicin—urinary bladder cancer	0.000456	0.000467	CcSEcCtD
Sotalol—Dermatitis—Doxorubicin—urinary bladder cancer	0.000455	0.000466	CcSEcCtD
Sotalol—Headache—Doxorubicin—urinary bladder cancer	0.000453	0.000464	CcSEcCtD
Sotalol—Nausea—Doxorubicin—urinary bladder cancer	0.000429	0.00044	CcSEcCtD
